KLARIFY
LIVE

Serial Number

79346056

Owner

ALK-Abelló A/S

Attorney

Monica Riva Talley

Filing Date

Feb 11, 2022

Add to watchlist:

No watchlists yet
View on USPTO

KLARIFY Trademark

Serial Number: 79346056

KLARIFY is a trademark filed by ALK-Abelló A/S on February 11, 2022. The trademark is classified under Class 10 (Medical Apparatus), Class 35 (Advertising & Business). The application is currently pending registration.

Owner Contact Info

ALK-Abelló A/S (37 trademarks)

Bøge Allé 6-8
DK-2970 Hørsholm , DK

Entity Type: 99

Trademark Details

Filing Date

February 11, 2022

Registration Date

Not Registered

Published for Opposition

May 12, 2026

Goods & Services

Testing apparatus for medical purposes, namely, immunochemical testing apparatus for medical use in relation to allergy and asthma; spirometers, namely, incentive spirometers for medical use; apparatus for carrying-out diagnostic tests for medical purposes, namely, medical diagnostic apparatus for testing for allergy and asthma; medical devices for self or home testing for allergy, namely, medical diagnostic apparatus for testing for allergies; electric devices for analyzing the condition of allergy and asthma patients, namely, medical diagnostic apparatus for detecting allergies and asthma; inhalers for medical or therapeutic use in relation to allergy and asthma; nebulizers for medical use in relation to allergy and asthma; nasal filters for medical purposes for allergy and asthma patients; none of the aforesaid goods for use in the cardiovascular field nor for use in continence management

Compilation and collection into a computer database of scientific and pharmaceutical data relating to allergy, asthma, allergic rhinitis, allergic asthma, rhinoconjunctivitis, respiratory allergic diseases as well as atopic dermatitis and food allergy; wholesale and retail store services, also online and via an e-commerce platform, featuring pharmaceutical and veterinary preparations for immunotherapeutic purposes, pharmaceutical and veterinary preparations for diagnosis, prevention and treatment of allergy, asthma, allergic rhinitis, allergic asthma, rhinoconjunctivitis, respiratory allergic diseases as well as atopic dermatitis and food allergy; wholesale and retail store services, also online and via an e-commerce platform, featuring diagnostic preparations for medical purposes, diagnostic reagents and diagnostic testing materials for medical use in the field of allergy, asthma, allergic rhinitis, allergic asthma, rhinoconjunctivitis, respiratory allergic diseases as well as atopic dermatitis and food allergy, eye drops, nose drops, nasal sprays; wholesale and retail store services, also online and via an e-commerce platform, featuring pharmaceutical preparations for inhalers, pharmaceutical preparations in the form of injectable pharmaceuticals, particularly adrenaline, for treatment of anaphylactic reactions; wholesale and retail store services, also online and via an e-commerce platform, featuring dietary and nutritional supplements for humans and for animals, food supplements for humans and for animals, food supplements in the form of peanut powder for the prevention of allergies in humans or animals, probiotic supplements for humans and animals, probiotic preparations for medical and veterinary use, also online and via an e-commerce platform, in relation to infant formula, namely, lactose free infant formula and hydrolyzed milk formula, additives for infant formula to prevent the development of allergies, food for babies, diagnostic testing materials for medical use, allergy and asthma testing kits, scientific, checking and supervision, life-saving and teaching apparatus and instruments, computer software, particularly computer software for medical use; wholesale and retail store services, also online and via an e-commerce platform, featuring diagnostic apparatus for testing food, namely, for mould detection, sensors for detecting and analyzing the presence of chemicals, toxins, mould and allergens in food, food components and food products, downloadable electronic publications in the nature of magazines and periodicals, electronic magazines and periodicals, online questionnaires; wholesale and retail store services, also online and via an e-commerce platform, featuring medical apparatus and instruments, testing apparatus for medical purposes, spirometers, namely, incentive spirometers for medical use; wholesale and retail store services, also online and via an e-commerce platform, featuring apparatus for carrying-out diagnostic tests for medical purposes, medical devices for self or home testing for allergy, electric devices for analysing the condition of allergy and asthma patients, inhalers for medical or therapeutic use, nebulizers for medical use, nasal filters; wholesale and retail store services, also online and via an e-commerce platform, featuring printed matter, instructional and teaching materials, magazines and periodicals, printed questionnaires; wholesale and retail store services, also online and via an e-commerce platform, featuring bed linen, edible oils derived from fish; all the aforesaid goods relating to allergy, asthma, allergic rhinitis, allergic asthma, rhinoconjunctivitis, respiratory allergic diseases as well as atopic dermatitis and food allergy; none of the aforesaid services in relation to the cardiovascular field nor in relation to continence management, but all in relation to allergy and asthma only

Filing History

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 12, 2026 NPUB
PUBLISHED FOR OPPOSITION
May 12, 2026 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 6, 2026 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 15, 2026 CNSA
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Oct 13, 2025 RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Apr 12, 2025 RCSC
NEW REPRESENTATIVE AT IB RECEIVED
Nov 1, 2024 NREP
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Oct 4, 2024 RCSC
DIVISIONAL PROCESSING COMPLETE
Aug 29, 2024 DPCC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Aug 12, 2024 AITU
DIVISIONAL REQUEST RECEIVED
Jun 17, 2024 DRRR
TEAS REQUEST TO DIVIDE RECEIVED
Jun 17, 2024 ERTD
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Mar 8, 2024 RCSC
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Jan 21, 2024 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jan 3, 2024 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Jan 3, 2024 OPNR
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Sep 8, 2023 GNS3
LETTER OF SUSPENSION E-MAILED
Sep 8, 2023 GNSL
SUSPENSION LETTER WRITTEN
Sep 8, 2023 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 1, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 31, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 31, 2023 TROA
REFUSAL PROCESSED BY IB
Feb 21, 2023 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jan 30, 2023 RFCS
REFUSAL PROCESSED BY MPU
Jan 30, 2023 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Dec 1, 2022 RFCR
NON-FINAL ACTION WRITTEN
Nov 30, 2022 CNRT
ASSIGNED TO EXAMINER
Nov 28, 2022 DOCK
APPLICATION FILING RECEIPT MAILED
Aug 5, 2022 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 1, 2022 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Jul 30, 2022 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jul 28, 2022 REPR